These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
524 related articles for article (PubMed ID: 26781720)
1. The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis. Zhang X; Ji L; Yang L; Tang X; Qin W Int Urol Nephrol; 2016 May; 48(5):731-43. PubMed ID: 26781720 [TBL] [Abstract][Full Text] [Related]
2. Moderator's view: The use of calcineurin inhibitors in the treatment of lupus nephritis. Kronbichler A; Neumann I; Mayer G Nephrol Dial Transplant; 2016 Oct; 31(10):1572-6. PubMed ID: 27591329 [TBL] [Abstract][Full Text] [Related]
4. Con: The use of calcineurin inhibitors in the treatment of lupus nephritis. Fernandez Nieto M; Jayne DR Nephrol Dial Transplant; 2016 Oct; 31(10):1567-71. PubMed ID: 27591328 [TBL] [Abstract][Full Text] [Related]
5. Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis. Mok CC Nephrol Dial Transplant; 2016 Oct; 31(10):1561-6. PubMed ID: 27591327 [TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and safety of tacrolimus, mycophenolate mofetil, azathioprine, and cyclophosphamide as maintenance therapy for lupus nephritis : A Bayesian network meta-analysis of randomized controlled trials. Lee YH; Song GG Z Rheumatol; 2017 Dec; 76(10):904-912. PubMed ID: 27638015 [TBL] [Abstract][Full Text] [Related]
7. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up. Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339 [TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials. Zhu B; Chen N; Lin Y; Ren H; Zhang W; Wang W; Pan X; Yu H Nephrol Dial Transplant; 2007 Jul; 22(7):1933-42. PubMed ID: 17405792 [TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of randomized controlled trials comparing tacrolimus with intravenous cyclophosphamide in the induction treatment for lupus nephritis. Deng J; Huo D; Wu Q; Yang Z; Liao Y Tohoku J Exp Med; 2012 Aug; 227(4):281-8. PubMed ID: 22820853 [TBL] [Abstract][Full Text] [Related]
11. Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Henderson LK; Masson P; Craig JC; Roberts MA; Flanc RS; Strippoli GF; Webster AC Am J Kidney Dis; 2013 Jan; 61(1):74-87. PubMed ID: 23182601 [TBL] [Abstract][Full Text] [Related]
12. Tacrolimus use in lupus nephritis: A systematic review and meta-analysis. Hannah J; Casian A; D'Cruz D Autoimmun Rev; 2016 Jan; 15(1):93-101. PubMed ID: 26427983 [TBL] [Abstract][Full Text] [Related]
13. Multitarget therapy versus intravenous cyclophosphamide in the induction treatment of lupus nephritis: a metaanalysis of randomized controlled trials. Deng J; Luo L; Zhu L; Xie H; xie H Turk J Med Sci; 2018 Oct; 48(5):901-910. PubMed ID: 30384552 [TBL] [Abstract][Full Text] [Related]
14. Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis. Lee YH; Woo JH; Choi SJ; Ji JD; Song GG Lupus; 2010 May; 19(6):703-10. PubMed ID: 20064907 [TBL] [Abstract][Full Text] [Related]
15. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial. Kamanamool N; Ingsathit A; Rattanasiri S; Ngamjanyaporn P; Kasitanont N; Chawanasuntorapoj R; Pichaiwong W; Anutrakulchai S; Sangthawan P; Ophascharoensuk V; Avihingsanon Y; Sumethkul V Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558 [TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: a meta-analysis. Feng L; Deng J; Huo DM; Wu QY; Liao YH Nephrology (Carlton); 2013 Feb; 18(2):104-10. PubMed ID: 23113811 [TBL] [Abstract][Full Text] [Related]
17. Relative efficacy and safety of calcineurin inhibitor, mycophenolate mofetil, and azathioprine as maintenance therapies for lupus nephritis: a network meta-analysis. Lee YH; Song GG Z Rheumatol; 2024 Feb; 83(Suppl 1):140-147. PubMed ID: 37278824 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of immunosuppressive drugs induction therapy for lupus nephritis: a systematic review and network meta-analysis. Dong Y; Shi J; Wang S; Liu Y; Yu S; Zhao L Ren Fail; 2023; 45(2):2290365. PubMed ID: 38087473 [TBL] [Abstract][Full Text] [Related]
19. Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy. Mao Y; Yin L; Huang H; Zhou Z; Chen T; Zhou W J Int Med Res; 2019 Jan; 47(1):105-113. PubMed ID: 30208769 [TBL] [Abstract][Full Text] [Related]
20. Comparative Efficacy and Safety of Tacrolimus, Cyclosporin A, Mycophenolate Mofetil, Cyclophosphamide, and Corticosteroids as Induction Therapy for Membranous Lupus Nephritis: A Network Meta-Analysis. Lee YH; Song GG Pharmacology; 2022; 107(9-10):439-445. PubMed ID: 35609529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]